12
Participants
Start Date
March 8, 2019
Primary Completion Date
December 31, 2022
Study Completion Date
October 20, 2023
Boston Children's Hospital, Boston
Collaborators (1)
BioMarin Pharmaceutical
INDUSTRY
Boston Children's Hospital
OTHER